China's pharmaceutical manufacturing development makes you proud!

In recent years, the global pharmaceutical market has maintained steady growth. According to IMS Health's forecast, from 2012 to 2017, the global pharmaceutical market will continue to expand at a compound annual growth rate of 5.3%, and it will reach a market size of 1.24 trillion US dollars in 2017. In this market, the development of China pharmaceutical manufacturing is definitely worth the pride from Chinese.

The pharmaceutical industry is an important part of China’s national economy. During the “Thirteenth Five-Year Plan” period, China’s rapid economic development and in-depth reform of the medical system prompted the continuous release of demand. China’s pharmaceutical industry’s main business income has increased year by year and exceeded 3 trillion yuan in 2017. The strong demand in the domestic market has become a driving force for the development of China's pharmaceutical industry, and has promoted China to become the world's second largest pharmaceutical consumer market. On the other hand, with the integration of the global economy and the growing international competitiveness of China's pharmaceutical industry, domestic pharmaceuticals have accelerated their pace in the world, prompting China to become the world's largest raw material drug producer and exporter. In 2017, the export of western medicines in China reached 35.456 billion U.S. dollars, an increase of 12.62%. Among them, raw material medicine exports 29.117 billion US dollars, an increase of 13.71%. The export of pharmaceutical preparations was US$3.456 billion, an increase of 8.32% over the same period of last year. Biochemicals exported 2.883 billion U.S. dollars, an increase of 7.36% year-on-year. The remarkable achievements fully demonstrated that China's pharmaceutical industry already has the ability to provide safe and reliable medical product supply systems to all countries in the world.

In the booming tide of China pharmaceutical manufacturing, Tasly has become the leader in this wave. As a leader in modernization and internationalization of traditional Chinese medicine, Tasly knows that pharmaceuticals and pharmaceuticals, especially Chinese medicines, must have their own core technologies and own intellectual property rights. Just as Chairman Yan Xijun of the Board of Directors of Tasly Holdings Group stated, “If we Chinese people do not own the most advanced technology and cannot do independent innovation, Chinese medicine cannot have a broader prospect!”. For this reason, in the modernization process of traditional Chinese medicine, Tasly’s innovative development has created too many industry firsts:

 Firstly proposed the concept of modern Chinese medicine and became a typical representative of the independent innovation of modern Chinese medicine in China.

· Create the first Chinese medicine planting base certified by the national GAP;

· First proposed the establishment of a modern Chinese medicine extraction and production quality management specification (GEP) standards;

· Promote GEP to expand in a more complete, dynamic, and more operational cGEP direction;

·Using full fingerprint analysis to solve the problems that traditional Chinese medicines that cannot be solved by traditional Chinese medicines like guaranteed clear ingredients and controllable quality;

and many more......

It is the effort to promote the modernization of Chinese medicine in China that has led Tasly successively gain approval for the “Construction State Key Laboratory of Innovative Traditional Chinese Medicine Key Technologies” and the “National Local Joint Engineering Laboratory for Advanced Manufacturing Technology of Traditional Chinese Medicine” and has obtained “National Enterprise Technical Center" title.

Facing the future, in the field of Chinese medicine manufacturing, especially in smart manufacturing, Tasly will serve as the “Intelligent Manufacturing Pilot Demonstration Unit” of the Ministry of Industry and Information Technology. In the process of pioneering the pilot, it will achieve significant development in key technologies, intelligent manufacturing equipment, and industrial software. , And boost China's pharmaceutical manufacturing industry in the fierce competition in the world's pharmaceutical manufacturing market!